We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.13%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.68B
AUM Growth
-$63.5M
Cap. Flow
-$190M
Cap. Flow %
-5.16%
Top 10 Hldgs %
14.27%
Holding
1,438
New
94
Increased
433
Reduced
653
Closed
139

Top Buys

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$8.59M
2
OXY icon
Occidental Petroleum
OXY
+$4.3M
3
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$4.05M
4
MTUM icon
iShares MSCI USA Momentum Factor ETF
MTUM
+$3.96M
5
KTB icon
Kontoor Brands
KTB
+$3.5M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$17.5M
2
AAPL icon
Apple
AAPL
+$14.3M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$10.7M
4
DD icon
DuPont de Nemours
DD
+$8.17M
5
JPM icon
JPMorgan Chase
JPM
+$7.8M

Sector Composition

Rank Sector Weight
1 Technology 13.28%
2 Healthcare 12.17%
3 Financials 11.04%
4 Consumer Discretionary 8.91%
5 Industrials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKBA icon
1276
Akebia Therapeutics
AKBA
$349M
$59K ﹤0.01%
12,100
-1,060
-8% -$6.03K
ATNM icon
1277
Actinium Pharmaceuticals
ATNM
$26.6M
$58K ﹤0.01%
7,876
+2,026
+35% +$20.4K
CNR
1278
DELISTED
Cornerstone Building Brands, Inc.
CNR
$58K ﹤0.01%
10,000
– –
HIMX
1279
Himax Technologies
HIMX
$2.19B
$49K ﹤0.01%
14,240
– –
WPG
1280
DELISTED
Washington Prime Group Inc.
WPG
$48K ﹤0.01%
+1,387
New +$56.9K
PDLI
1281
DELISTED
PDL BioPharma, Inc.
PDLI
$48K ﹤0.01%
15,188
– –
TEUM
1282
DELISTED
Pareteum Corporation
TEUM
$45K ﹤0.01%
+17,080
New +$67.6K
ASXC
1283
DELISTED
Asensus Surgical, Inc.
ASXC
$44K ﹤0.01%
2,462
– –
MIND icon
1284
MIND Technology
MIND
$44.4M
$40K ﹤0.01%
1,000
– –
IBRX icon
1285
ImmunityBio
IBRX
$7.59B
$33K ﹤0.01%
32,600
– –
JCP
1286
DELISTED
J.C. Penney Company, Inc.
JCP
$33K ﹤0.01%
28,900
-500
-2% -$594
OPK icon
1287
Opko Health
OPK
$993M
$29K ﹤0.01%
11,714
-600
-5% -$1.31K
NGD
1288
DELISTED
New Gold Inc
NGD
$27K ﹤0.01%
28,146
– –
SZC.RT
1289
DELISTED
Cushing Renaissance Fund
SZC.RT
$23K ﹤0.01%
+109,310
New +$22.7K
OIG
1290
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$22K ﹤0.01%
681
– –
DMK
1291
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$21K ﹤0.01%
229
-14
-6% -$1.7K
GSM icon
1292
FerroAtlántica
GSM
$592M
$20K ﹤0.01%
12,230
-1,000
-8% -$1.9K
ATHX
1293
DELISTED
Athersys, Inc. Common Stock
ATHX
$17K ﹤0.01%
400
– –
AXAS
1294
DELISTED
Abraxas Petroleum Corp
AXAS
$15K ﹤0.01%
725
– –
QUIK icon
1295
QuickLogic
QUIK
$233M
$13K ﹤0.01%
1,631
-11
-0.7% -$111
CGRN
1296
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$12K ﹤0.01%
1,530
+300
+24% +$2.56K
GSAT icon
1297
Globalstar
GSAT
$10.7B
$5K ﹤0.01%
680
-334
-33% -$2.62K
AMPE
1298
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$4K ﹤0.01%
34
– –
AA icon
1299
Alcoa
AA
$12B
– –
-8,362
Closed -$235K
AEE icon
1300
Ameren
AEE
$30.4B
– –
-4,183
Closed -$307K
50 51
52
53 54

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q2 2019 Portfolio in Review

As of Q2 2019, Oppenheimer & Co held 1,438 positions worth $3.68B, down 1.7% from $3.74B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $190M in Q2 2019, closing 139 positions and reducing 653 holdings. Its most notable exit was Amber Road Inc, an estimated $2.06M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oppenheimer & Co opened a new position in Dow Inc worth $8.02M.

  • Oppenheimer & Co's largest Q2 2019 buy was Dow Inc: 162,710 shares worth $8.02M.
  • Oppenheimer & Co added most to Occidental Petroleum in Q2 2019, an estimated $4.3M increase.
  • Oppenheimer & Co's biggest Q2 2019 reduction was Invesco QQQ Trust, cutting an estimated $17.5M.
  • Oppenheimer & Co fully exited Amber Road Inc in Q2 2019, selling an estimated $2.06M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.68B portfolio in Q2 2019.
  • Oppenheimer & Co opened 94 new positions and closed 139 in Q2 2019.
  • Oppenheimer & Co's portfolio value fell 1.7% quarter-over-quarter to $3.68B.

Based on Oppenheimer & Co's 13F filing for Q2 2019, filed 9 Aug 2019.